Phase II Trial of Cisplatin Plus Decitabine, a New DNA Hypomethylating Agent, in Patients With Advanced Squamous Cell Carcinoma of the Cervix
2002 ◽
Vol 25
(5)
◽
pp. 496-501
◽
1992 ◽
Vol 31
(2)
◽
pp. 167-169
◽
2008 ◽
Vol 31
(1)
◽
pp. 29-33
◽